Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448955
Status:
COMPLETED
Last Update Posted:
2008-04-18
First Post:
2007-03-16
Brief Title:
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Sponsor:
Ardana Bioscience Ltd
Organization:
Ardana Bioscience Ltd
Study Overview
Official Title:
A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403 a Testosterone Cream in Testosterone Deficient Men
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Male hypogonadism a disorder associated with testosterone deficiency is frequently seen in clinical practice and has significant effects on patient wellbeing The purpose of this study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy in testosterone deficient men
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None